RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells

Fanconi anemia complementation group F protein (FANCF) is a key factor, which maintains the function of FA/BRCA, a DNA damage response pathway. However, the functional role of FANCF in breast cancer has not been elucidated. We performed a specific FANCF-shRNA knockdown of endogenous FANCF in vitro....

Full description

Bibliographic Details
Main Authors: L. Zhao, N. Li, J.K. Yu, H.T. Tang, Y.L. Li, M. He, Z.J. Yu, X.F. Bai, Z.H. Zheng, E.H. Wang, M.J. Wei
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2014-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2014000100024&lng=en&tlng=en
_version_ 1819176955191230464
author L. Zhao
N. Li
J.K. Yu
H.T. Tang
Y.L. Li
M. He
Z.J. Yu
X.F. Bai
Z.H. Zheng
E.H. Wang
M.J. Wei
author_facet L. Zhao
N. Li
J.K. Yu
H.T. Tang
Y.L. Li
M. He
Z.J. Yu
X.F. Bai
Z.H. Zheng
E.H. Wang
M.J. Wei
author_sort L. Zhao
collection DOAJ
description Fanconi anemia complementation group F protein (FANCF) is a key factor, which maintains the function of FA/BRCA, a DNA damage response pathway. However, the functional role of FANCF in breast cancer has not been elucidated. We performed a specific FANCF-shRNA knockdown of endogenous FANCF in vitro. Cell viability was measured with a CCK-8 assay. DNA damage was assessed with an alkaline comet assay. Apoptosis, cell cycle, and drug accumulation were measured by flow cytometry. The expression levels of protein were determined by Western blot using specific antibodies. Based on these results, we used cell migration and invasion assays to demonstrate a crucial role for FANCF in those processes. FANCF shRNA effectively inhibited expression of FANCF. We found that proliferation of FANCF knockdown breast cancer cells (MCF-7 and MDA-MB-435S) was significantly inhibited, with cell cycle arrest in the S phase, induction of apoptosis, and DNA fragmentation. Inhibition of FANCF also resulted in decreased cell migration and invasion. In addition, FANCF knockdown enhanced sensitivity to doxorubicin in breast cancer cells. These results suggest that FANCF may be a potential target for molecular, therapeutic intervention in breast cancer.
first_indexed 2024-12-22T21:18:59Z
format Article
id doaj.art-31cac723498d498595279486c87964d9
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-12-22T21:18:59Z
publishDate 2014-01-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-31cac723498d498595279486c87964d92022-12-21T18:12:14ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2014-01-01471243410.1590/1414-431X20132938S0100-879X2014000100024RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cellsL. ZhaoN. LiJ.K. YuH.T. TangY.L. LiM. HeZ.J. YuX.F. BaiZ.H. ZhengE.H. WangM.J. WeiFanconi anemia complementation group F protein (FANCF) is a key factor, which maintains the function of FA/BRCA, a DNA damage response pathway. However, the functional role of FANCF in breast cancer has not been elucidated. We performed a specific FANCF-shRNA knockdown of endogenous FANCF in vitro. Cell viability was measured with a CCK-8 assay. DNA damage was assessed with an alkaline comet assay. Apoptosis, cell cycle, and drug accumulation were measured by flow cytometry. The expression levels of protein were determined by Western blot using specific antibodies. Based on these results, we used cell migration and invasion assays to demonstrate a crucial role for FANCF in those processes. FANCF shRNA effectively inhibited expression of FANCF. We found that proliferation of FANCF knockdown breast cancer cells (MCF-7 and MDA-MB-435S) was significantly inhibited, with cell cycle arrest in the S phase, induction of apoptosis, and DNA fragmentation. Inhibition of FANCF also resulted in decreased cell migration and invasion. In addition, FANCF knockdown enhanced sensitivity to doxorubicin in breast cancer cells. These results suggest that FANCF may be a potential target for molecular, therapeutic intervention in breast cancer.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2014000100024&lng=en&tlng=enFanconi anemia complementation group F proteinBreast neoplasmsTumor cell line
spellingShingle L. Zhao
N. Li
J.K. Yu
H.T. Tang
Y.L. Li
M. He
Z.J. Yu
X.F. Bai
Z.H. Zheng
E.H. Wang
M.J. Wei
RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells
Brazilian Journal of Medical and Biological Research
Fanconi anemia complementation group F protein
Breast neoplasms
Tumor cell line
title RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells
title_full RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells
title_fullStr RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells
title_full_unstemmed RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells
title_short RNAi-mediated knockdown of FANCF suppresses cell proliferation, migration, invasion, and drug resistance potential of breast cancer cells
title_sort rnai mediated knockdown of fancf suppresses cell proliferation migration invasion and drug resistance potential of breast cancer cells
topic Fanconi anemia complementation group F protein
Breast neoplasms
Tumor cell line
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2014000100024&lng=en&tlng=en
work_keys_str_mv AT lzhao rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells
AT nli rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells
AT jkyu rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells
AT httang rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells
AT ylli rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells
AT mhe rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells
AT zjyu rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells
AT xfbai rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells
AT zhzheng rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells
AT ehwang rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells
AT mjwei rnaimediatedknockdownoffancfsuppressescellproliferationmigrationinvasionanddrugresistancepotentialofbreastcancercells